A comparison of the efficacy and tolerability of interferon beta (IFNβ) products used as initial or follow-up therapy for the treatment of relapsing multiple sclerosis:: Results from the QUASIMS study

被引：0
|
作者：
Limmroth, V
Malessa, R
Kalski, G
Wernsdörfer, C
机构：
来源：
NEUROLOGY | 2004年 / 62卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A155 / A156
页数：2
相关论文
共 50 条
  • [1] A comparison of the efficacy and tolerability of interferon-beta (IFNb) products used as initial or follow-up therapy for the treatment of relapsing multiple sclerosis:: results from the QUASIMS Study
    Limmroth, V
    Malessa, R
    Kalski, G
    Wernsdörfer, C
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 : 54 - 54
  • [2] Final results from the Global QUASIMS Study: a worldwide comparative study of the efficacy and tolerability of interferon-beta products for the treatment of relapsing multiple sclerosis
    Limmroth, V.
    Putzki, N.
    [J]. MULTIPLE SCLEROSIS, 2007, 13 : S55 - S55
  • [3] Comparison of the efficacy and tolerability of interferon-beta in the treatment of relapsing-remitting multiple sclerosis:: Spanish results from the international QUASIMS study
    Sanchez-Solino, O.
    Guerrero-Esteo, M.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S188 - S188
  • [4] Results from the global QUASIMS study:: Comparison of the efficacy and tolerability of interferon beta (IFNb) products for the treatment of relapsing multiple sclerosis in Australia, Brazil, Belgium, Italy and Slovakia
    Limmroth, V
    Wernek, L
    Nagels, G
    Lugaresi, A
    Kalski, G
    Wernsdörfer, C
    [J]. NEUROLOGY, 2005, 64 (06) : A325 - A326
  • [5] QUASIMS: a worldwide comparative study of interferon-beta products for relapsing multiple sclerosis
    Limmroth, V
    Werneck, L
    Nagels, G
    Lugaresi, A
    Kalski, G
    Wernsdoerfer, C
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 : 131 - 131
  • [6] QUASIMS comparative study of interferon-beta products for relapsing multiple sclerosis: results from Belgium, Netherlands, and Luxembourg
    Nagels, G
    Debruyne, J
    Sanders, E
    Yang, S
    Tinbergen, J
    Limmroth, V
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 : 45 - 45
  • [7] A comparative study of interferon-beta products for relapsing-remitting multiple sclerosis: QUASIMS results from Italy
    Lugaresi, A
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 : 45 - 45
  • [8] QUASIMS:: An observational study in Germany on interferon beta preparations as therapy for relapsing multiple sclerosis
    Putzki, N.
    Limmroth, V.
    Malessa, R.
    Zettl, U. K.
    Koehler, J.
    Japp, G.
    Haller, P.
    Elias, W.
    Obhof, W.
    Viehoever, A.
    Meier, U.
    Brosig, A.
    Hasford, J.
    Kalski, G.
    Wernsdoerfer, C.
    [J]. AKTUELLE NEUROLOGIE, 2007, 34 (01) : 1 - 7
  • [9] Quality Assessment in Multiple Sclerosis Therapy (QUASIMS)A comparison of interferon beta therapies for relapsing-remitting multiple sclerosis
    Volker Limmroth
    Rolf Malessa
    Uwe Klaus Zettl
    Jürgen Koehler
    Gudrun Japp
    Peter Haller
    Wolfgang Elias
    Winfried Obhof
    Andrea Viehöver
    Uwe Meier
    Arne Brosig
    Joerg Hasford
    Norman Putzki
    Gabriele Kalski
    Colin Wernsdörfer
    [J]. Journal of Neurology, 2007, 254 : 67 - 77
  • [10] Quality assessment in multiple sclerosis therapy (QUASIMS) -: A comparison of interferon beta therapies for relapsing-remitting multiple sclerosis
    Limmroth, Volker
    Malessa, Rolf
    Zettl, Uwe Klaus
    Koehler, Juergen
    Japp, Gudrun
    Haller, Peter
    Elias, Wolfgang
    Obhof, Winfried
    Viehoever, Andrea
    Meier, Uwe
    Brosig, Arne
    Hasford, Joerg
    Putzki, Norman
    Kalski, Gabriele
    Wernsdoerfer, Colin
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 (01) : 67 - 77
12345